Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May.

Valbiotis, specialized in the development and marketing of dietary supplements for the prevention and fight against metabolic disorders causing cardiovascular diseases, announces the French launch, as of May, of Valbiotis®PRO Cholestérol, a dietary supplement composed exclusively from Lipidrive® (formerly-TOTUM•070), a patented active ingredient of 100% natural origin for the management of mild to moderate hypercholesterolemia.

Valbiotis®PRO Cholestérol is a clinically tested non-drug solution for managing mild to moderate hypercholesterolemia. The result of nearly 10 years of Research & Development, Lipidrive®, the non-drug active substance contained in Valbiotis®PRO Cholestérol is patented in 19 countries.

100% natural origin, it has been the subject of 2 clinical efficacy studies (HEART and OLALIP), meeting the most exacting standards.

Valbiotis®PRO Cholestérol will be available on schedule in pharmacies and via the Company’s website this May.

More information: https://www.biopole-clermont.com/wp-content/uploads/2024/04/2024_04_03-PR_VALBIOTIS_LIPIDRIVE.pdf